Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

chinadaily.com.cn - Pharma firms obliged to make medicines even if unprofitable - Opinion
Pharma firms obliged to make medicines even if unprofitable - Opinion
中国日报网

Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC] AFTER MEDIA REPORTS about a shortage, even in some big hospitals, of mercapatopurinem, a medication used to treat…

standard.co.uk - Helen Corbett - NHS services will not be cut to fund US pharma deal - Streeting
NHS services will not be cut to fund US pharma deal - Streeting
Evening Standard

Sign up for our email featuring expert insight and funding opportunities for entrepreneurs and SMEs I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. No NHS services will be cut to fund a…

independent.co.uk - Helen Corbett - NHS services will not be cut to fund US pharma deal - Streeting
NHS services will not be cut to fund US pharma deal - Streeting
The Independent

No NHS services will be cut to fund a zero-tariff deal with the US, the Health Secretary has insisted amid questions over how much it will cost the UK. The deal keeps tariffs on imports of UK pharmaceuticals into the US at zero for three years in…

globenewswire.com - Pharma Equity Group A/S - Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026
Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026
GlobeNewswire

Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026 Pharma Equity Group A/S (“PEG”) announces that the Company's agreement with Danske Bank as liquidity provider will terminate…

afr.com - Michael Smith - Dennis Bastas' rise from aspiring car designer to $5b pharma king
Dennis Bastas' rise from aspiring car designer to $5b pharma king
Australian Financial Review

It was Dennis Bastas' crowning moment after 20 years of deal-making. The healthcare entrepreneur in August sold a 25 per cent stake in his pharmaceutical and beauty empire DBG Health for $1.6 billion, valuing the company he built from scratch at a…

republicworld.com - Avishek Banerjee - ED Attaches ₹2.04 Crore Assets of Chennai Pharma Firm Owner in Toxic Cough Syrup Deaths Case
ED Attaches ₹2.04 Crore Assets of Chennai Pharma Firm Owner in Toxic Cough Syrup Deaths Case
Republic World

The Enforcement Directorate's Chennai zonal office has attached assets valued at ₹2.04 crore belonging to G. Ranganathan, proprietor of Sresan Pharmaceutical Manufacturer, in connection with a money-laundering probe linked to the fatal…

cityam.com - Gareth Lyon - Britain is missing out on pharma investment thanks to medicine rationing
Britain is missing out on pharma investment thanks to medicine rationing
City AM

A subtle version of fiscal drag has seen the amount the NHS is prepared to spend on treatments reduce in real terms, meaning patients are missing out on life-saving treatment and the economy is missing out on investment, says Gareth Lyon The UK…

independent.com - Nick Welsh - Santa Barbara County to Get $4.4 Million in Purdue Pharma Opioid Settlement
Santa Barbara County to Get $4.4 Million in Purdue Pharma Opioid Settlement
The Santa Barbara Independent

With the White House's new war on drugs now crossing unprecedented moral, legal, and diplomatic boundaries, it's worth noting that the County of Santa Barbara is currently poised to receive $4.4 million over 15 years as part of Purdue Pharma's…

statnews.com - Ed Silverman - Pharmalittle: We're reading about FDA's Pazdur retiring, Europe's reaction to U.S.-U.K. pharma deal, and more
Pharmalittle: We're reading about FDA's Pazdur retiring, Europe's reaction to U.S.-U.K. pharma deal, and more
STAT

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you…

dorsetecho.co.uk - PA News Agency - NHS services will not be cut to fund US pharma deal - Streeting
NHS services will not be cut to fund US pharma deal - Streeting
Dorset Echo

The deal keeps tariffs on imports of UK pharmaceuticals into the US at zero for three years in return for the NHS raising its threshold for spending on new medicines by 25%. Downing Street has said the cost would start small and gradually increase…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Trading Down 6.1% - What's Next?
Urogen Pharma (NASDAQ:URGN) Trading Down 6.1% - What's Next?
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) shares dropped 6.1% during trading on Tuesday. The company traded as low as $26.87 and last traded at $26.72. Approximately 242,123 shares changed hands during mid-day trading, a decline of 83% from the…

rediff.com - Senjo M R - Coldrif syrup maker used industrial-grade materials: ED
Coldrif syrup maker used industrial-grade materials: ED
Rediff.com

The manufacturer of Coldrif syrup, whose consumption is alleged to have killed at least 20 children in Madhya Pradesh, used industrial-grade raw materials instead of pharma-grade sans quality checks to prepare the medicine, an Enforcement…

benzinga.com - Erica Kollmann - Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say - Capricor Therapeutics (NASDAQ:CAPR)
Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say - Capricor Therapeutics (NASDAQ:CAPR)
Benzinga

Capricor Therapeutics, Inc. (NASDAQ:) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate, deramiocel. CAPR stock is soaring. See the real-time price action…

marketbeat.com - 100,000 Shares in Royalty Pharma PLC $RPRX Acquired by Watchtower Advisors LP
100,000 Shares in Royalty Pharma PLC $RPRX Acquired by Watchtower Advisors LP
MarketBeat

Watchtower Advisors LP purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 100,000 shares of…

thehindubusinessline.com - Pharma firm Corona Remedies IPO to open on Dec 8; sets price band at ₹1,008-1,062/ share
Pharma firm Corona Remedies IPO to open on Dec 8; sets price band at ₹1,008-1,062/ share
BusinessLine

Headquartered in Ahmedabad, Corona Remedies is a pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas Pharma firm…

Receive a Daily briefing on Pharma Industry News

Get Started